RECURRENT AL AMYLOIDOSIS

Clinical trials for RECURRENT AL AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new RECURRENT AL AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for RECURRENT AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat amyloidosis

Disease control Recruiting now

This early-phase study is testing the safety and best dose of a three-drug combination (venetoclax, ixazomib, and dexamethasone) for adults with light chain amyloidosis that has returned or stopped responding to prior treatments. The study is specifically for patients who have a …

Matched conditions: RECURRENT AL AMYLOIDOSIS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

RECURRENT AL AMYLOIDOSIS

Get alerted when new RECURRENT AL AMYLOIDOSIS trials appear

New drug combo tested for Tough-to-Treat amyloidosis